Author name: DrugChatter

If you spend enough time around athletes, weekend warriors, or anyone optimizing “fitness,” you start to notice a recurring theme: […]

Why migraine drugs became weight-loss forums, cholesterol pills turned into food-interaction experiments, and cancer therapies spawned Reddit-scale crowdsourced medicine. There’s

Inside the wonderfully unfiltered world of drug questions people actually ask online Spend enough time around pharmaceutical R&D and you

AI Pharmacovigilance: How Drug Companies Track Safety Signals Before Regulators Do The FDA receives roughly 2 million adverse event reports

Chatbots now answer drug questions that once required a detail rep, a pharmacist, or a Medical Information call center. The

AI Agents Now Influence Which Drugs Patients Ask For — Here’s the Pharma Playbook When a patient with newly diagnosed

On September 30, 2004, Merck pulled Vioxx from every pharmacy shelf in the world. The withdrawal took less than 24

The channel shift is not hypothetical. Patients and prescribers are asking AI chatbots about drug dosing, side effects, and alternatives

Spend enough time watching patient questions, and a pattern emerges: it’s not just “does this work?” or “is this safe?”—it’s

If you want to understand drug shortages, don’t start with FDA dashboards. Start with patient questions. They don’t say “supply

An investigative report on how large language models misrepresent prescription drugs, what that costs manufacturers, and why most brand teams

A look at the $50B opportunity reshaping how pharma companies launch, monitor, and defend their brands in the age of